EdgeWater Research Partners Recently Initiated Coverage of GeoPharma (GORX): $7.25 Target Price
EdgeWater Research Partners, LLC (www.edgewaterresearch.com), an independent micro cap equities research company, has initiated coverage on GeoPharma, Inc. with an 18- to 24-month target price of $7.25 and an allocation rating of four or Buy. EdgeWater tracks a variety of undiscovered small and micro cap stocks through both individual research and its monthly publication, The EdgeWater Micro Monthly. With nearly 300 employees and operations in Florida, Maryland, Pennsylvania, Nevada, Rhode Island and Texas, GeoPharma, Inc. is a biotech/pharmaceutical company that specializes in the formulation, manufacturing and distribution of generic drugs and the development of oncology-related medical devices. The company distributes…